TrialBreast cancer research and treatment2021

The efficacy and safety of enzalutamide with trastuzumab in patients with HER2+ and androgen receptor-positive metastatic or locally advanced breast cancer.

Andrew Wardley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.